[1] Bulte JW, Kraitchman DL.Iron oxide MR contrast agents for molecular and cellular imaging[J].NMR Biomed, 2004, 17(7): 484-499.
[2] Luciqnani G, Ottobrini L, Martelli C, et al.Molecular imaging of cell-mediated cancer immunotherapy[J].Trends Biotechnol, 2006, 24(9): 410-418.
[3] Li L, Jiang W, Luo K, et al.Superparamagnetic iron oxide nanoparticles as MRI contrast agents for non-invasive stem cell labeling and tracking[J].Theranostics, 2013, 3(8): 595-615.
[4] Li M, Kim HS, Tian L, et al.Comparison of two ultrasmall superparamagnetic iron oxides on cytotoxicity and MR imaging of tumors[J].Theranostics, 2012, 2(1): 76-85.
[5] Valable S, Barbier EL, Bernaudin M, et al.In vivo MRI tracking of exogenous monocytes/macrophages targeting brain tumors in a rat model of glioma[J].Neuroimage, 2008, 40(2): 973-983.
[6] Arbab AS, Yocum GT, Kalish H, et al.Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI[J].Blood, 2004, 104(4): 1217-1223.
[7] Wang L, Wang Z, Frank TG, et al.Rapid and efficient cell labeling with a MRI contrast agent by electroporation in the presence of protamine sulfate[J].Nanomedicine(Lond), 2009, 4(3): 305-315.
[8] Lewin M, Carlesso N, Tung CH, et al.Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells[J].Nat Biotechnol, 2000, 18(4): 410-414.
[9] Langenkamp A, Messi M, Lanzavecchia A, et al.Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells[J].Nat Immunol, 2000, 1(4): 311-316.
[10] Figdor CG, de Vries IJ, Leaterhuis WJ, et al.Dendritic cell immunotherapy: mapping the way[J].Nat Med, 2004, 10(5): 475-480.
[11] de Vries IJ, Leaterhuis WJ, Barentsz JO, et al.Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy[J].Nat Biotechnol, 2005, 23(11): 1407-1413.
[12] Aspord C, Laurin D, Janier MF, et al.Paramagnetic nanoparticles to track and quantify in vivo immune human therapeutic cells[J].Nanoscale, 2013, 5(23): 11409-11415.
[13] Rohani R, de Chickera SN, Willert C, et al.In vivo cellular MRI of dendritic cell migration using micrometer-sized iron oxide(MPIO)particles[J].Mol Imaging Biol, 2011, 13(4): 679-694.
[14] Liu L, Ye Q, Wu Y, et al.Tracking T-cells in vivo with a new nano-sized MRI contrast agent[J].Nanomedicine, 2012, 8(8): 1345-1354.
[15] Shapiro EM, Medford-Davis LN, Fahmy TM, et al.Antibody-mediated cell labeling of peripheral T cells with micron-sized iron oxide particles (MPIOs)allows single cell detection by MRI[J].Contrast Media Mol Imaging, 2007, 2(3): 147-153.
[16] Petry KG, Boiziau C, Dousset V, et al.Magnetic resonance imaging of human brain macrophage infiltration[J].Neurotherapeutics, 2007, 4(3): 434-442.
[17] Figueiredo S, Cutrin JC, Rizzitelli S, et al.MRI tracking of macrophages labeled with glucan particles entrapping a water insoluble paramagnetic Gd-based agent[J].Mol Imaging Biol, 2013, 15(3): 307-315.
[18] Jinushi M, Takehara T, Tatsumi T, et al.Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to the altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection[J].J Immunol, 2004, 173(10): 6072-6081.
[19] Farag SS, Caliqiuri MA.Human natural killer cell development and biology[J].Blood Rev, 2006, 20(3): 123-137.
[20] Albertsson PA, Basse PH, Hokland M, et al.NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity[J].Trends Immunol, 2003, 24(11): 603-609.
[21] Mallett CL, McFadden C, Chen Y, et al.Migration of iron-labeled KHYG-1 natural killer cells to subcutaneous tumors in nude mice, as detected by magnetic resonance imaging[J].Cytotherapy, 2012, 14(6): 743-751.
[22] Meier R, Golovko D, Tavri S, et al.Depicting adoptive immunotherapy for prostate cancer in an animal model with magnetic resonance imaging[J].Magn Reson Med, 2011, 65(3): 756-763.